The Federal Reserve now needs to be on Trump watch if it wants to engineer the proper dose of monetary policy, according to Bank of America chief Brian Moynihan. "They've got a new administration with a new set of fiscal policies,

CNBC's Jim Cramer on Wednesday told investors there will be a shift in Wall Street's focus, from the actions of the Federal Reserve to those of President Donald Trump. "We're now looking at the changing of the guard from Powell to Trump," he said. "It won't be easy, as one's a pretty predictable guy and the other's a wild card."

After two years of progress on inflation and surprisingly persistent economic growth, the Federal Reserve next week meets with one eye on new Trump administration policies and another on a bond market that has ratcheted up borrowing costs even as U.

President Donald Trump doesn’t like to wait, and patience is exactly what the Federal Reserve is serving right now. After December’s strong jobs report, the Fed seems comfortable sitting tight, keeping interest rates steady instead of cutting them.

President Donald Trump started his second administration with a blitz of policy actions to reorient the U.S. government.

Investors considering alternative strategies should proactively adjust their portfolios to anticipate these potential changes.

Several large U.S. financial institutions, including the Federal Reserve, have withdrawn from the networks after years of growing political and legal pressure.

Democratic-led states and civil rights groups filed a slew of lawsuits challenging U.S. President Donald Trump's bid to roll back birthright citizenship on Tuesday in an early bid by his opponents to block his agenda in court.

Following Trump's inauguration, the Federal Reserve will hold its first policy meeting of the year. Though economists believe the Fed won't raise or lower interest rates on Jan. 29, investors will be looking for any signals to inform their risk assessment and trading strategy, all of which could impact the direction of mortgage rates.

Trump's VA pick, former Rep. Doug Collins, said the VA may be trying to fill positions, but many of those vacancies have gone unfilled for weeks or longer.

The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.